Psoriatic arthritis: advances in pharmacotherapy based on molecular target

Author： Scarpa Raffaele Costa Luisa Atteno Mariangela Del Puente Antonio Caso Francesco Moll John MH

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.17, 2013-12, pp. : 2311-2313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the treatment of psoriatic arthritis

By Pipitone Nicolò Pitzalis Costantino

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 509-525

Informa Healthcare

Access to resources Recommend Favorite

Psoriatic arthritis

By Brockbank J. Gladman D.D.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1511-1522

Informa Healthcare

Access to resources Recommend Favorite

Emerging Advances in Nanomedicine as a Nanoscale Pharmacotherapy in Rheumatoid Arthritis: State of the Art

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 2, 2017-01 ,pp. : 162-173

Bentham Science Publishers

Access to resources Recommend Favorite

Traditional and Newer Therapeutic Options for Psoriatic Arthritis: An Evidence-Based Review

By Gladman Dafna D.

Drugs, Vol. 65, Iss. 9, 2005-01 ,pp. : 1223-1238

Adis International

Access to resources Recommend Favorite

Adalimumab: In Psoriatic Arthritis

By Simpson Dene Scott Lesley J.

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1487-1496

Adis International

Access to resources Recommend Favorite